Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 204-209

  Zheng, Shuning ^a   Yu, Mingyang ^a   Lu, Xiumei ^a   Huo, Taoguang ^a   Ge, Lin ^a   Yang, Jingyu ^a   Wu, Chunfu ^a   Li, Famei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chronic unpredictable mild stress; Depression; Metabonomics; UPLC MS; Urine

Indexed keywords

2 OXOGLUTARIC ACID; CITRIC ACID; CREATININE; HIPPURIC ACID; INDICAN; INDOLEACETIC ACID; KYNURENIC ACID; N2 SUCCINYL ORITHINE; ORNITHINE; PHENYLACETYLGLYCINE; PHENYLALANINE; SUCROSE; TRIPEPTIDE; TRYPTOPHAN; UNCLASSIFIED DRUG; XANTHURENIC ACID;

AGGRESSION; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CHRONIC STRESS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; ENERGY METABOLISM; GROOMING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLORA; MALE; MASS SPECTROMETRY; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; URINALYSIS;

AMINO ACIDS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSIVE DISORDER; ENERGY METABOLISM; GASTROINTESTINAL TRACT; MALE; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MULTIVARIATE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PHYSIOLOGICAL; SUCROSE; UNCERTAINTY;

ANIMALIA; RATTUS;

EID: 72449182598     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.003     Document Type: Article

References (53)

1. Shenal B.V., Harrison D.W., and Demaree H.A. The neuropsychology of depression: a literature review and preliminary model. Neuropsychol Rev 13 (2003) 33-42
2. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 11-38
3. Hatzinger M. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression. World J Biol Psychiatry 1 (2000) 105-111
4. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134 (1997) 319-329
5. Paige L.A., Mitchell M.W., Krishnan K.R., Kaddurah-Daouk R., and Steffens D.C. A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry 22 (2007) 418-423
6. Michell A.W., Mosedale D., Grainger D.J., and Barker R.A. Metabolomic analysis of urine and serum in Parkinson's disease. Metabolomics 4 (2008) 191-201
7. Huang J.T., Leweke F.M., Tsang T.M., et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS ONE 2 (2007) e756
8. Lan M.J., McLoughlin G.A., Griffin J.L., et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 14 (2009) 269-279
9. Ni Y., Su M., Lin J., et al. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett 582 (2008) 2627-2636
10. Yin P., Mohemaiti P., Chen J., et al. Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 871 (2008) 322-327
11. Plumb R.S., Granger J.H., Stumpf C.L., et al. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130 (2005) 844-849
12. Li F., Lu X., Liu H., Liu M., and Xiong Z. A pharmaco-metabonomic study on the therapeutic basis and metabolic effects of Epimedium brevicornum Maxim on hydrocortisone-induced rat using UPLC-MS. Biomed Chromatogr 21 (2007) 397-405
13. Wang X., Zhao T., Qiu Y., et al. A metabonomics approach to understanding acute and chronic stress in rat models. J Proteome Res 8 (2009) 2511-2518
14. Griffin J.L., Anthony D.C., Campbell S.J., et al. Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine. FEBS Lett 568 (2004) 49-54
15. Grippo A.J., Beltz T.G., Weiss R.M., and Johnson A.K. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. J Biol Psychiatry 59 (2006) 309-316
16. Grønli J., Murison R., Fiske E., et al. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 84 (2005) 571-577
17. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93 (1987) 358-364
18. Papp M., Willner P., and Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104 (1991) 255-259
19. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16 (1992) 525-534
20. Chan W., and Cai Z. Aristolochic acid induced changes in the metabolic profile of rat urine. J Pharm Biomed Anal 46 (2008) 757-762
21. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 207-217
22. Corcos M., Guilbaud O., Hjalmarsson L., Chambry J., and Jeammet P. Cytokines and depression: an analogic approach. Biomed Pharmacother 56 (2002) 105-110
23. Wood K., Harwood J., Swade C., and Coppen A. Decreased tryptophan excretion by depressive patients. Clin Chim Acta 88 (1978) 57-61
24. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 113 (1967) 1237-1264
25. Mauri M.C., Ferrara A., Boscati L., et al. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37 (1998) 124-129
26. Maes M., Wauters A., Verkerk R., et al. Lower serum l-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology 15 (1996) 243-251
27. Owens M.J., and Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40 (1994) 288-295
28. Neumayer V.E., Riederer P., Danielczyk W., and Seemann D. Biochemical findings in the brain in endogenous depression. Wien Med Wochenschr 125 (1975) 344-349
29. Mangoni A. The "kynurenine shunt" and depression. Adv Biochem Psychopharmacol 11 (1974) 293-298
30. Takeuchi F., Tsubouchi R., Izuta S., and Shibata Y. Kynurenine metabolism and xanthurenic acid formation in vitamin B6-deficient rat after tryptophan injection. J Nutr Sci Vitaminol (Tokyo) 35 (1989) 111-122
31. Okuda S., Nishiyama N., Saito H., and Katsuki H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70 (1998) 299-307
32. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 Suppl 1 (2003) S119-S124
33. Capuron L., Neurauter G., Musselman D.L., et al. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54 (2003) 906-914
34. Wichers M., and Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 5 (2002) 375-388
35. van West D., and Maes M. Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuro Endocrinol Lett 20 (1999) 11-17
36. Maes M., Scharpé S., Meltzer H.Y., et al. Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 54 (1994) 143-160
37. O'Connor J.C., Lawson M.A., André C., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Mol Psychiatry 14 (2009) 511-522
38. Hoekstra R., van den Broek W.W., Fekkes D., Bruijn J.A., Mulder P.G., and Pepplinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res 103 (2001) 115-123
39. Hashimoto R., Ozaki N., Ohta T., Kasahara Y., Kaneda N., and Nagatsu T. Plasma tetrahydrobiopterin levels in patients with psychiatric disorders. Neuropsychobiology 23 (1990-1991) 140-143
40. Anderson D.N., Wilkinson A.M., Abou-Saleh M.T., and Blair J.A. Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Acta Psychiatr Scand 90 (1994) 10-13
41. Sahlin K., Tonkonogi M., and Söderlund K. Energy supply and muscle fatigue in humans. Acta Physiol Scand 162 (1998) 261-266
42. Serretti A., Mandelli L., Lattuada E., and Smeraldi E. Depressive syndrome in major psychoses: a study on 1351 subjects. Psychiatry Res 127 (2004) 85-99
43. Chung K.T., Anderson G.M., and Fulk G.E. Formation of indoleacetic acid by intestinal anaerobes. J Bacteriol 124 (1975) 573-575
44. Banoglu E., Jha G.G., and King R.S. Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. Eur J Drug Metab Pharmacokinet 26 (2001) 235-240
45. Jann A., Stalon V., Wauven C.V., Leisinger T., and Haas D. N2-Succinylated intermediates in an arginine catabolic pathway of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 83 (1986) 4937-4941
46. Phipps A.N., Stewart J., Wright B., and Wilson I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28 (1998) 527-537
47. Delaney J., Neville W.A., Swain A., Miles A., Leonard M.S., and Waterfield C.J. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers 9 (2004) 271-290
48. Riederer P., Toifl K., and Kruzik P. Excretion of biogenic amine metabolites in anorexia nervosa. Clin Chim Acta 123 (1982) 27-32
49. Ladep N.G., Obindo T.J., Audu M.D., Okeke E.N., and Malu A.O. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 12 (2006) 7844-7847
50. Mine K., Matsumoto K., and Kanazawa F. The relation between irritable bowel syndrome and a major depression. Nippon Rinsho 50 (1992) 2719-2723
51. O'Mahony S.M., Marchesi J.R., Scully P., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65 (2009) 263-267
52. Logan A.C., and Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 64 (2005) 533-538
53. Desbonnet L., Garrett L., Clarke G., Bienenstock J., and Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43 (2008) 164-174